Holen Sie sich die Stockscreener-App
4.16
4.26%
0.17
Vorhandelsmarkt:
4.16
Schlusskurs vom Vortag:
$3.99
Offen:
$3.9
24-Stunden-Volumen:
152.81K
Relative Volume:
0.08
Marktkapitalisierung:
$8.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-27.02%
1M Leistung:
+72.61%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$3.8628
$4.50
1-Wochen-Bereich:
$3.4502
$6.18
52-Wochen-Spanne:
$2.20
$9.309
Longevity Health Holdings Inc Stock (XAGE) Company Profile
Firmenname
Longevity Health Holdings Inc
Sektor
Telefon
412-894-8248
Adresse
2403 SIDNEY STREET, SUITE 300, PITTSBURGH
Vergleichen Sie XAGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XAGE
Longevity Health Holdings Inc
|
4.16 | 8.46M | 0 | 0 | 0 | 0.00 |
|
PG
Procter Gamble Co
|
158.32 | 357.96B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
60.34 | 147.74B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
88.70 | 71.44B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
22.67 | 41.07B | 15.30B | 1.06B | 1.45B | 0.55 |
|
KMB
Kimberly Clark Corp
|
128.89 | 42.06B | 19.75B | 2.47B | 2.39B | 7.34 |
Longevity Health Holdings Inc Aktie (XAGE) Neueste Nachrichten
Is Longevity Health Holdings Inc. a good long term investmentRobust investment performance - jammulinksnews.com
Longevity Health Holdings Inc. Stock Analysis and ForecastHigh-velocity gains - jammulinksnews.com
What analysts say about Longevity Health Holdings Inc. stockGame-changing capital returns - jammulinksnews.com
Is Longevity Health Holdings Inc. Equity Warrant a good long term investmentRecord-setting profit potential - jammulinksnews.com
What drives Longevity Health Holdings Inc. stock priceMassive portfolio appreciation - jammulinksnews.com
What drives Longevity Health Holdings Inc. Equity Warrant stock priceStrongest growth potential - jammulinksnews.com
Should I buy Longevity Health Holdings Inc. stock before earningsMarket Ready Callouts - Newser
What makes Longevity Health Holdings Inc. stock price move sharplyFree Risk Assessment Services - Newser
What makes Longevity Health Holdings Inc. Equity Warrant stock price move sharplyFree Professional Portfolio Management - Newser
Longevity Health Holdings Inc. Equity Warrant Stock Analysis and ForecastHigh-velocity gains - Autocar Professional
What analysts say about Longevity Health Holdings Inc. Equity Warrant stockAccelerated financial growth - Autocar Professional
Longevity Health Shares Skyrocket After All-Stock Merger with THPlasma - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders - The Malaysian Reserve
Halper Sadeh investigates Onconetix, Waters, and Longevity Health Holdings mergers. - AInvest
What analysts say about Longevity Health Holdings Inc. Equity Warrant stock outlookWeekly Big Movers - Newser
Is Longevity Health Holdings Inc. stock a growth or value playSafe High Return Entry Points - Newser
Best Growth Stocks To Research – July 15th - Defense World
Trade Desk Shares Surge 15% Amid S&P 500 Inclusion - AInvest
Why Longevity Health Holdings Inc. stock attracts strong analyst attentionFree VIP Group - Newser
How Longevity Health Holdings Inc. stock performs during market volatilityFree Investment Community - Newser
Why Longevity Health Stock Is Skyrocketing Today - Benzinga
Pre-Market Movers: Navigating Volatility with Technical and Event-Driven Insights - AInvest
XAGE Eyes Plasma-Led Expansion After Dropping 20/20 BioLabs Deal - Investing.com
Longevity Health Holdings Inc’s Shares Reel: 51.42% Quarterly Revenue Decline Amid 5.69M Market Cap - investchronicle.com
Why Longevity Health Holdings Inc. Equity Warrant stock attracts strong analyst attentionFree Access to Community - Newser
XAGE Shares Surge: Should You Dive In? - StocksToTrade
Dow Falls Over 100 Points; JPMorgan Posts Upbeat Earnings - Benzinga
Finanzdaten der Longevity Health Holdings Inc-Aktie (XAGE)
Es liegen keine Finanzdaten für Longevity Health Holdings Inc (XAGE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):